Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Shines Biotechnology Co. Ltd. currently has 1 pending office action within the Medical Devices & Mechanical Engineering technology area. This action is being reviewed by 1 distinct examiner, DUKERT, BRIAN AINSLEY. The prosecution of this application is the primary focus of the company's current activity at the USPTO.
The portfolio involves 1 distinct art unit, which provides a specific technical context for the examination. DUKERT, BRIAN AINSLEY is the busiest examiner for the portfolio, with 1 busiest examiner pending action. This indicates that the entire pending docket is managed by 1 distinct examiner within 1 distinct art unit.
Practitioners should focus on the specific examination patterns of DUKERT, BRIAN AINSLEY to advance the 1 pending office action. Since there is only 1 distinct art unit, the applicant can apply a consistent strategy without the need to reconcile different art unit policies. The 1 busiest examiner pending action represents the only current matter requiring a response from the applicant.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DUKERT, BRIAN AINSLEY | 1 | 82.1% | +11.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18177530 | COMPOSITE DECELLULARIZED MATRIX MEMBRANE AND USE THEREOF | DUKERT, BRIAN AINSLEY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18177530 | COMPOSITE DECELLULARIZED MATRIX MEMBRANE AND USE THEREOF | DUKERT, BRIAN AINSLEY | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18177530 | COMPOSITE DECELLULARIZED MATRIX MEMBRANE AND USE THEREOF | DUKERT, BRIAN AINSLEY | 3774 | §102§112 | Final Rejection | — | Pending | Mar 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialShines Biotechnology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Brian Ainsley Dukert has the most, with 1 of Shines Biotechnology Co. Ltd.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
